We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+5.41%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.2B
AUM Growth
+$172M
(+0.43%)
Cap. Flow
-$1.31B
Cap. Flow
% of AUM
-3.26%
Top 10 Holdings %
Top 10 Hldgs %
18.88%
Holding
794
New
108
Increased
186
Reduced
363
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$427M |
| 2 |
RTN
Raytheon Company
RTN
|
+$193M |
| 3 |
RTX Corp
RTX
|
+$181M |
| 4 |
Marathon Petroleum
MPC
|
+$163M |
| 5 |
Deere & Co
DE
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$263M |
| 2 |
DuPont de Nemours
DD
|
+$238M |
| 3 |
Walmart Inc
WMT
|
+$216M |
| 4 |
Ross Stores
ROST
|
+$195M |
| 5 |
Fortive
FTV
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.26% |
| 2 | Technology | 15.21% |
| 3 | Financials | 12.82% |
| 4 | Consumer Discretionary | 11.4% |
| 5 | Industrials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Synchrony
SYF
$24.4B
| $70.2M | 0.17% |
2,025,038
-192,617
| -9% | -$6.53M |
|
152
Willis Towers Watson
WTW
$29.8B
| $69M | 0.17% |
360,175
-18,100
| -5% | -$3.28M |
|
|
153
DuPont de Nemours
DD
$18.6B
| $69M | 0.17% |
731,835
-1,997,402
| -73% | -$238M |
|
154
S&P Global
SPGI
$124B
| $68.4M | 0.17% |
300,411
-11,971
| -4% | -$2.61M |
|
155
General Motors
GM
$80.9B
| $67.6M | 0.17% |
1,754,986
+1,292,120
| +279% | +$48.4M |
|
|
NVMI
156
Nova
NVMI
$11.7B
| $67.5M | 0.17% |
2,638,690
+1,240,000
| +89% | +$33.2M |
|
157
Huntington Ingalls Industries
HII
$11B
| $67.3M | 0.17% |
299,419
-168,154
| -36% | -$36M |
|
|
VISN
158
Vistance Networks Inc
VISN
$2.61B
| $65.9M | 0.16% |
+4,191,996
| New | +$85.1M |
|
159
Crown Castle
CCI
$34.6B
| $65.8M | 0.16% |
505,094
-15,100
| -3% | -$1.94M |
|
160
Illumina
ILMN
$29.5B
| $65.8M | 0.16% |
183,803
-5,832
| -3% | -$1.84M |
|
|
AMRN
161
Amarin Corp
AMRN
$297M
| $65.4M | 0.16% |
168,750
+45,000
| +36% | +$16.5M |
|
162
Norfolk Southern
NSC
$75.4B
| $64.8M | 0.16% |
324,906
-10,000
| -3% | -$1.98M |
|
163
MDU Resources
MDU
$4.18B
| $64.5M | 0.16% |
+6,574,713
| New | +$64M |
|
164
American Express
AXP
$224B
| $64.1M | 0.16% |
519,225
-103,500
| -17% | -$12.2M |
|
165
Dover
DOV
$26.7B
| $63.5M | 0.16% |
633,513
+299,248
| +90% | +$28.7M |
|
166
Marvell Technology
MRVL
$147B
| $63.4M | 0.16% |
2,656,179
+294,812
| +12% | +$6.89M |
|
167
Zoetis
ZTS
$32.7B
| $63.2M | 0.16% |
557,039
-16,700
| -3% | -$1.75M |
|
168
Automatic Data Processing
ADP
$109B
| $63.1M | 0.16% |
381,924
-103,300
| -21% | -$16.8M |
|
|
AGN
169
DELISTED
Allergan plc
AGN
| $62.9M | 0.16% |
375,399
+50,930
| +16% | +$7.05M |
|
|
MRSH
170
Marsh
MRSH
$94.3B
| $61.5M | 0.15% |
616,604
-232,100
| -27% | -$22.2M |
|
171
Prologis
PLD
$136B
| $61.4M | 0.15% |
767,029
-22,200
| -3% | -$1.69M |
|
|
STML
172
DELISTED
Stemline Therapeutics, Inc.
STML
| $61.3M | 0.15% |
4,000,000
+500,000
| +14% | +$7.23M |
|
|
GRA
173
DELISTED
W.R. Grace & Co.
GRA
| $60.9M | 0.15% |
+799,600
| New | +$59.9M |
|
174
Capital One
COF
$128B
| $60.8M | 0.15% |
670,582
+85,500
| +15% | +$7.65M |
|
175
Bunge Global
BG
$20.9B
| $60.7M | 0.15% |
1,088,918
-800,000
| -42% | -$42.7M |
|
Similar funds
Adage Capital Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Adage Capital Partners held 794 positions worth $40.2B, up 0.43% from $40B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Adage Capital Partners withdrew a net $1.31B in Q2 2019, closing 91 positions and reducing 363 holdings. Its most notable exit was InflaRx, an estimated $85.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in Raytheon Company worth $186M.
- Adage Capital Partners's largest Q2 2019 buy was Raytheon Company: 1,071,108 shares worth $186M.
- Adage Capital Partners added most to Celgene Corp in Q2 2019, an estimated $427M increase.
- Adage Capital Partners's biggest Q2 2019 reduction was Honeywell, cutting an estimated $263M.
- Adage Capital Partners fully exited InflaRx in Q2 2019, selling an estimated $85.9M.
- Adage Capital Partners's ten largest holdings make up 19% of its $40.2B portfolio in Q2 2019.
- Adage Capital Partners opened 108 new positions and closed 91 in Q2 2019.
- Adage Capital Partners's portfolio value rose 0.43% quarter-over-quarter to $40.2B.
Based on Adage Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.